Suppr超能文献

甲氨蝶呤作为异位妊娠和妊娠滋养细胞肿瘤治疗方法的演变:综述

The evolution of methotrexate as a treatment for ectopic pregnancy and gestational trophoblastic neoplasia: a review.

作者信息

Skubisz Monika M, Tong Stephen

机构信息

Translational Obstetrics Group, Department of Obstetrics and Gynaecology, University of Melbourne, Mercy Hospital for Women, Heidelberg, 3084 VIC, Australia.

出版信息

ISRN Obstet Gynecol. 2012;2012:637094. doi: 10.5402/2012/637094. Epub 2012 Feb 19.

Abstract

Methotrexate was developed in 1949 as a synthetic folic acid analogue to compete with folic acid and thus interfere with cell replication. While initially developed as a potential treatment for acute lymphoblastic leukaemia, a serendipitous observation led to methotrexate's use to effect the dramatic cure of a case of advanced choriocarcinoma. This prompted the exploration for the potential of methotrexate to treat other conditions involving disordered trophoblastic tissue. Methotrexate has subsequently revolutionized the treatment of two pregnancy-related conditions-gestational trophoblastic neoplasia and ectopic pregnancy. This article reviews the development of modern treatment protocols that use methotrexate to medically treat these two important gynaecological conditions.

摘要

甲氨蝶呤于1949年被开发出来,作为一种合成叶酸类似物,与叶酸竞争,从而干扰细胞复制。虽然最初是作为急性淋巴细胞白血病的潜在治疗方法开发的,但一次意外的观察导致甲氨蝶呤被用于成功治愈一例晚期绒毛膜癌。这促使人们探索甲氨蝶呤治疗其他涉及滋养层组织紊乱疾病的潜力。随后,甲氨蝶呤彻底改变了两种与妊娠相关疾病——妊娠滋养细胞肿瘤和异位妊娠的治疗方法。本文回顾了使用甲氨蝶呤药物治疗这两种重要妇科疾病的现代治疗方案的发展历程。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7441/3302016/4bf54c95cb8d/ISRN.OBGYN2012-637094.001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验